Zanubrutinib
Zanubrutinib, sold under the brand name Brukinsa, is for the treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy. Reference standards of Zanubrutinib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => (S)-7-(1-Acryloylpiperidin-4-yl)-4-nitroso-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide
[catalogue_number] => PA 26 0391000
[category_ids] => ,70,75,76,78,82,162,
[chemical_name] =>
[weight] => 500.56
[form] => C27H28N6O4
[cas] => NA
[pslug] => s-7-1-acryloylpiperidin-4-yl-4-nitroso-2-4-phenoxyphenyl-4-5-6-7-tetrahydropyrazolo-1-5-a-pyrimidine-3-carboxamide-pa260391000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
(S)-7-(1-Acryloylpiperidin-4-yl)-4-nitroso-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide
Catalogue No.:PA 26 0391000
Molecular Formula : C27H28N6O4
Molecular Weight : 500.56
